9-12704725-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000550.3(TYRP1):c.1261+20C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.525 in 1,608,578 control chromosomes in the GnomAD database, including 243,064 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.41 ( 16520 hom., cov: 32)
Exomes 𝑓: 0.54 ( 226544 hom. )
Consequence
TYRP1
NM_000550.3 intron
NM_000550.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.07
Genes affected
TYRP1 (HGNC:12450): (tyrosinase related protein 1) This gene encodes a melanosomal enzyme that belongs to the tyrosinase family and plays an important role in the melanin biosynthetic pathway. Defects in this gene are the cause of rufous oculocutaneous albinism and oculocutaneous albinism type III. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 9-12704725-C-T is Benign according to our data. Variant chr9-12704725-C-T is described in ClinVar as [Benign]. Clinvar id is 256642.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-12704725-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.593 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TYRP1 | NM_000550.3 | c.1261+20C>T | intron_variant | ENST00000388918.10 | NP_000541.1 | |||
LURAP1L-AS1 | NR_125775.1 | n.317-4099G>A | intron_variant | |||||
TYRP1 | XM_047423841.1 | c.*128C>T | downstream_gene_variant | XP_047279797.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TYRP1 | ENST00000388918.10 | c.1261+20C>T | intron_variant | 1 | NM_000550.3 | ENSP00000373570.4 |
Frequencies
GnomAD3 genomes AF: 0.411 AC: 62433AN: 151736Hom.: 16519 Cov.: 32
GnomAD3 genomes
AF:
AC:
62433
AN:
151736
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.447 AC: 111897AN: 250122Hom.: 30244 AF XY: 0.448 AC XY: 60655AN XY: 135246
GnomAD3 exomes
AF:
AC:
111897
AN:
250122
Hom.:
AF XY:
AC XY:
60655
AN XY:
135246
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.537 AC: 782561AN: 1456724Hom.: 226544 Cov.: 33 AF XY: 0.530 AC XY: 384129AN XY: 724996
GnomAD4 exome
AF:
AC:
782561
AN:
1456724
Hom.:
Cov.:
33
AF XY:
AC XY:
384129
AN XY:
724996
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.411 AC: 62437AN: 151854Hom.: 16520 Cov.: 32 AF XY: 0.405 AC XY: 30070AN XY: 74214
GnomAD4 genome
AF:
AC:
62437
AN:
151854
Hom.:
Cov.:
32
AF XY:
AC XY:
30070
AN XY:
74214
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
467
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 16, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Oculocutaneous albinism type 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at